Results 11 to 20 of about 1,097 (151)

Disseminated Lomentospora prolificans infection presenting with arterial exsanguination [PDF]

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2021
Lomentospora prolificans is an opportunistic fungal pathogen found especially in Australia, Spain, Portugal, California, and the southern United States. Although it causes a wide spectrum of infections, disseminated L.
Abdullah Nasif, MD   +5 more
doaj   +5 more sources

Lomentospora prolificans: An Emerging Opportunistic Fungal Pathogen [PDF]

open access: yesMicroorganisms, 2022
Lomentospora prolificans is an emerging opportunistic pathogen that primarily affects immunocompromised individuals leading to disseminated disease with high mortality rates while also causing infections in healthy populations.
Afroditi Konsoula   +5 more
doaj   +4 more sources

Lomentospora prolificans Disseminated Infections: A Systematic Review of Reported Cases [PDF]

open access: yesPathogens, 2022
Background: Lomentospora prolificans, a rare, highly virulent filamentous fungus with high rates of intrinsic resistance to antifungals, has been associated with different types of infections in immunocompromised as well as immunocompetent individuals ...
Afroditi Konsoula   +4 more
doaj   +4 more sources

Lomentospora prolificans synthesizes several types of melanin [PDF]

open access: yesmSphere
Lomentospora prolificans is a filamentous fungus with a global distribution, exhibiting a particularly higher prevalence in human-impacted environments.
Livia C. Liporagi-Lopes   +5 more
doaj   +4 more sources

Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France [PDF]

open access: yesEmerging Infectious Diseases
Scedosporium spp. and Lomentospora prolificans are emerging non-Aspergillus filamentous fungi. The Scedosporiosis/lomentosporiosis Observational Study we previously conducted reported frequent fungal vascular involvement, including aortitis and ...
Carole Vignals   +28 more
doaj   +5 more sources

Scedosporium apiospermum and Lomentospora prolificans emergent ocular infections in North India [PDF]

open access: yesIndian Journal of Ophthalmology
Settings: Identification of the prevalent species and report clinical features, predisposing factors, and visual outcomes of ocular infections caused by Scedosporium/Lomentospora in a tertiary care eye centre North India. Patient/Study Population: During
Karnika Saigal   +12 more
doaj   +4 more sources

A case of Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim [PDF]

open access: yesJournal of Ophthalmic Inflammation and Infection
Purpose To report a case of endogenous Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim. Case report A 57-year-old man developed disseminated Lomentospora prolificans with right endophthalmitis on the background ...
Michael Dong   +3 more
doaj   +4 more sources

Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole. [PDF]

open access: yesPLoS ONE, 2017
The filamentous fungus Lomentospora (Scedosporium) prolificans is an emerging opportunistic pathogen associated with fatal infections in patients with disturbed immune function.
Aize Pellon   +5 more
doaj   +10 more sources

Disseminated Lomentospora prolificans infection that could have been predicted: A case report [PDF]

open access: yesIDCases
Lomentospora prolificans is a rare, filamentous fungus, that causes a disseminated infection in immunocompromised individuals. Disseminated infections caused by the fungus are difficult to diagnose early. It is resistant to multiple antifungal agents and
Koga Sato   +4 more
doaj   +4 more sources

Microwave-Assisted Synthesis of Aminophosphonic Derivatives and Their Antifungal Evaluation against Lomentospora prolificans [PDF]

open access: yesMolecules, 2023
Lomentospora prolificans is a pathogenic and multidrug-resistant fungus that can infect both immunocompetent and immunocompromised patients, with mortality rates up to 87%.
Zuleyma Martínez-Campos   +5 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy